Bayer Children's Aspirin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

74 API Suppliers, 24 USDMF, 8 CEP/COS, 2 JDMF, 2 KDMF, 24 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

109 Drugs in Development

109 Drugs in Development

FINISHED DOSAGE FORMULATIONS

638 FDF Dossiers, 117 FDA Orange Book, 271 Europe, 89 Canada, 8 Australia, 32 South Africa, 121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 8 Evonik, 12 Rochem International Inc, 32 SPI Pharma, 30 DKSH, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 15 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 12 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 40 BASF, 1 Bioplus Life Sciences, 5 CD Formulation, 3 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 2 Esteem Industries, 3 Finar, 16 Gangwal Chemicals, 15 Ideal Cures, 5 Ingredion Pharma Solutions, 27 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 19 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 86 Coating Systems & Additives, 69 Thickeners and Stabilizers, 55 Solubilizers, 49 Direct Compression, 49 Disintegrants & Superdisintegrants, 47 Taste Masking, 46 Controlled & Modified Release, 45 Parenteral, 42 Granulation, 38 Topical, 33 Film Formers & Plasticizers, 31 Lubricants & Glidants, 27 Chewable & Orodispersible Aids, 19 Emulsifying Agents, 18 Rheology Modifiers, 17 Co-Processed Excipients, 14 Surfactant & Foaming Agents, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 194 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 38 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

60 APIs, 43 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 JP, 12 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20884 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
aspirin(UNII: R16CO5Y76E) (aspirin - UNII:R16CO5Y76E)	aspirin	25mg
dipyridamole(UNII: 64ALC7F90C) (dipyridamole - UNII:64ALC7F90C)	dipyridamole	200mg

Inactive Ingredients

Ingredient Name	Teva Pharmaceuticals USA, Inc.
ACACIA(5C5403N26O)
ALUMINUM STEARATE(U6XF9NP8HM)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
DIMETHICONE(92RU3N3Y1O)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
GELATIN(2G86QN327L)
HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)(8LDD2V82F5)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)(74G4R6TH13)
POVIDONE(FZ989GH94E)
SILICON DIOXIDE(ETJ7Z6XBU4)
STARCH, CORN(O8232NY3SJ)
STEARIC ACID(4ELV7Z65AP)
SUCROSE(C151H8M554)
TALC(7SEV7J4R1U)
TARTARIC ACID(W4888I119H)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIACETIN(XHX3C3X673)

Setid 1f059a7a 8fd4 48a9 A36d Daa6dcc93c81 Applno 20884 Form Capsule Extended Release Oral Dosage 25mg 200mg - Drug Product Composition: Bayer Children's Aspirin